硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 OAZ1 抗体对
试剂盒

人 OAZ1 抗体对

01AB01268

Ornithine decarboxylase antizyme 1 (OAZ1) is a regulatory protein that plays a crucial role in controlling intracellular polyamine levels by negatively regulating ornithine decarboxylase (ODC) activity and polyamine uptake, thereby influencing cell growth and proliferation. OAZ1 is widely expressed in human tissues and is part of the antizyme family, which modulates polyamine biosynthesis through a unique mechanism involving ribosomal frameshifting in response to polyamine concentrations, ensuring the production of functional antizyme only when polyamine levels are high. Structurally, OAZ1 binds to ODC, targeting it for proteasomal degradation, and its interaction with ODC is influenced by specific amino acid residues, as demonstrated by mutagenesis studies. In terms of disease relevance, OAZ1 has been shown to inhibit proliferation and induce differentiation in certain cancer cells, such as oral cancer, suggesting a potential tumor-suppressive role by limiting excessive polyamine-driven cell growth.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
OAZ1
基因别名
OAZ
蛋白别名
ornithine decarboxylase antizyme 1; OAZ1
UniProt
P54368
物种
Human

产品详情

靶点名称
OAZ1
蛋白名称
ornithine decarboxylase antizyme 1
蛋白别名
Ornithine decarboxylase antizyme 1; AZ1; ODC-Az
靶点基因名
OAZ1
基因别名
OAZ
UniProt
P54368
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Ornithine decarboxylase antizyme 1 (OAZ1) is a regulatory protein that plays a crucial role in controlling intracellular polyamine levels by negatively regulating ornithine decarboxylase (ODC) activity and polyamine uptake, thereby influencing cell growth and proliferation. OAZ1 is widely expressed in human tissues and is part of the antizyme family, which modulates polyamine biosynthesis through a unique mechanism involving ribosomal frameshifting in response to polyamine concentrations, ensuring the production of functional antizyme only when polyamine levels are high. Structurally, OAZ1 binds to ODC, targeting it for proteasomal degradation, and its interaction with ODC is influenced by specific amino acid residues, as demonstrated by mutagenesis studies. In terms of disease relevance, OAZ1 has been shown to inhibit proliferation and induce differentiation in certain cancer cells, such as oral cancer, suggesting a potential tumor-suppressive role by limiting excessive polyamine-driven cell growth.